Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03835949
Title Study of TJ004309 in Combination With Atezolizumab (Tecentriq) in Patients With Advanced or Metastatic Cancer
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tracon Pharmaceuticals Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
The University of Alabama at Birmingham Birmingham Alabama 35294 United States Details
HonorHealth Research Institute Scottsdale Arizona 85258 United States Details
City of Hope Duarte California 91010 United States Details
MD Anderson Cancer Center Houston Texas 77230 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field